Vaccinations versus Lockdowns to Prevent COVID-19 Mortality

Measures employed to combat COVID-19 included public lockdowns and vaccination campaigns. Israel's extensive public health system produced data demonstrating the real-world results of these measures. Our objective was to evaluate the health and economic outcomes of the measures to cope with COVID-19. Publicly available datasets from the Israeli Ministry of Health were used to model the parameters of the pandemic in Israel. The Oxford COVID-19 Government Response Tracker was used for quantitative data on government policies. Data on the Israeli economy were taken from the Central Bureau of Statistics. Our models demonstrate that the first lockdown prevented 1022 COVID-19 deaths at the cost of 36.4-38.6 billion NIS. The second lockdown prevented 1970 COVID-19 deaths and cost 18-21 billion NIS. These lifesaving effects were observed with a time lag from the declaration of lockdown. The primary vaccination campaign cost 1 billion NIS and prevented 4750 COVID-19 deaths. The first vaccination booster campaign prevented 650 COVID-19 deaths and cost 51.1 million NIS. Therefore, the cost per prevented COVID-19 death is 10-36 million NIS with a national lockdown versus 210,000 NIS in the primary vaccination campaign and 79,000 NIS in the first booster campaign. In conclusion, both lockdowns and vaccination campaigns effectively lower COVID-19 deaths, but the cost to avoid one COVID-19 death with effective vaccination is 50-466 times lower than with a lockdown.

Automated summary

The study evaluated the health and economic outcomes of lockdowns and vaccination campaigns to combat COVID-19. Both the first and second lockdowns, as well as the primary vaccination campaign, effectively prevented COVID-19 deaths. However, the cost per prevented COVID-19 death is significantly lower with effective vaccination compared to a national lockdown.